ArticleFrontiers in immunology

Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing?

Athar Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.